InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,973.10
(
0.74%
)
US TECH 100
20,519.20
(
-0.11%
)
Dow Jones
43,729.34
(
0.00%
)
Brent Oil
74.51
(
-1.27%
)
Bitcoin
75,981.02
(
0.11%
)
Post# of 253552
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: tinkershaw post# 67646

Wednesday, 10/22/2008 6:57:39 PM

Wednesday, October 22, 2008 6:57:39 PM

Post# of 253552
"The efficacy in crohns is outstanding. "

this is debatable. unlike MS, Tysabri efficacy is Crohn's in not more effective than otehr therapies.

Keep in mind that the non-carrier analysis in the ph 2 only included 9 pts per arm
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up